Directory
>
Douglas Fuhrer Dabt
Douglas Fuhrer Dabt
Executive Director Toxicology | BioXcel Therapeutics, Inc.
United States
Douglas Fuhrer Dabt
Summary
Douglas Fuhrer Dabt is a seasoned Executive Director and board-certified PhD toxicologist with a wealth of experience in drug discovery and development within the pharmaceutical industry. He has a proven track record of successful FDA submissions and the advancement of therapeutics across various indications. His expertise spans numerous disciplines, including toxicology, biochemistry, and clinical research, making him a versatile leader in the field. Douglas has held senior roles in both corporate and consulting environments, showcasing his adaptability and strategic vision. His educational background is robust, with advanced degrees in biochemistry and molecular biology, complemented by post-doctoral training in cytokine signal transduction. He is passionate about driving innovation in pharmaceuticals and improving drug safety. Douglas is known for his ability to lead multidisciplinary teams and foster collaboration in complex projects. He is committed to advancing scientific quality and reliability in drug development.
Douglas Fuhrer Dabt
Work Experience
Executive Director Toxicology at
BioXcel Therapeutics, Inc.
July 2021 - Present
President at
Djc Safety Consulting
January 2010 - Present
Scientific Director at
WuXi AppTec
January 2014 - July 2021
Senior Director at
Ricercatoxikon
January 2010 - January 2014
Director of Toxicology/Head Toxicologist at
Threshold Pharmaceuticals Intermune
January 2006 - January 2010
Head of Safety Pharmacology/Associate Director of Toxicology at
Quintiles Transnational Aptuit
January 2003 - January 2005
Molecular Toxicologist at
AstraZeneca
January 2001 - January 2003
Douglas Fuhrer Dabt
Education
Indiana University School of Medicine, Post-Doctoral Training
Northern Illinois University, Master Of Science - Ms
Northern Illinois University, Bachelor Of Science - Bs
Frequently Asked Questions about Douglas Fuhrer Dabt
What is Douglas Fuhrer Dabt email address?
Douglas Fuhrer Dabt's primary email address is *******@bioxceltherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Douglas Fuhrer Dabt work for?
Douglas Fuhrer Dabt is a Executive Director Toxicology at BioXcel Therapeutics, Inc., a company specializing in Scientific Research & Development Services.
Where Douglas Fuhrer Dabt graduated from?
Douglas Fuhrer Dabt holds a degree in Biochemistry And Molecular Biology from University of Illinois Urbana-Champaign.
How can I directly contact Douglas Fuhrer Dabt?
To contact Douglas Fuhrer Dabt directly, you can use the email address *******@bioxceltherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Douglas Fuhrer Dabt?
Douglas Fuhrer Dabt is a seasoned Executive Director and board-certified PhD toxicologist with a wealth of experience in drug discovery and development within the pharmaceutical industry. He has a proven track record of successful FDA submissions and the advancement of therapeutics across various indications. His expertise spans numerous disciplines, including toxicology, biochemistry, and clinical research, making him a versatile leader in the field. Douglas has held senior roles in both corporate and consulting environments, showcasing his adaptability and strategic vision. His educational background is robust, with advanced degrees in biochemistry and molecular biology, complemented by post-doctoral training in cytokine signal transduction. He is passionate about driving innovation in pharmaceuticals and improving drug safety. Douglas is known for his ability to lead multidisciplinary teams and foster collaboration in complex projects. He is committed to advancing scientific quality and reliability in drug development.
Douglas`s contact details
*******@bioxceltherapeutics.com
**************@wuxiapptec.com
Colleagues
Executive Director, Head Information Technology & Management
Vice President, Artificial Intelligence Drug Discovery
Chief Medical Officer, Neuroscience
Vice President of Neuroscience
Executive Director, Medical Managed Care & HEOR
Senior VP & Head, Translational Medicine, Clinical Pharmacology & Regulatory Affairs
Vice President, Oncology- Preclinical Development and Drug Discovery
Chief Executive Officer
VP Commercial Development and Medical Affairs
Vice President